Clinical Trials · NCT05394519
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,200
- Start date
- Feb 2023
- Locations
- 179 sites, 13 countries
- Primary endpoint
- Relative change in body weight